文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies.

作者信息

Henriksen-Lacey Malou, Bramwell Vincent, Perrie Yvonne

机构信息

School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.

出版信息

Pharmaceutics. 2010 Mar 31;2(2):91-104. doi: 10.3390/pharmaceutics2020091.


DOI:10.3390/pharmaceutics2020091
PMID:27721345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3986709/
Abstract

A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing adjuvants the ability to follow both the adjuvant and the antigen is favourable. To this end, we have devised a dual-radiolabelling method whereby the adjuvant (liposomes) is labelled with ³H and the antigen (a subunit protein) with I. This model is stable and reproducible; we have shown release of the radiolabels to be negligible over periods of up to 1 week in foetal calf serum at 37 ºC. In this paper we describe the techniques which enable the radiolabelling of various components, assessing stability and processing of samples which all for their application in biodistribution studies. Furthermore we provide examples derived from our studies using this model in tuberculosis vaccine biodistribution studies.

摘要

相似文献

[1]
Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies.

Pharmaceutics. 2010-3-31

[2]
Comparison of three remote radiolabelling methods for long-circulating liposomes.

J Control Release. 2015-10-26

[3]
A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice.

Vaccine. 2016-3-8

[4]
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Int J Pharm. 2008-12-8

[5]
Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.

Rev Physiol Biochem Pharmacol. 2018

[6]
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

Vaccine. 2008-3-4

[7]
Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.

Biochim Biophys Acta. 2014-8

[8]
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

J Control Release. 2012-3-27

[9]
Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.

J Liposome Res. 2011-12-22

[10]
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.

BMC Res Notes. 2017-1-26

引用本文的文献

[1]
Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System.

Pharmaceutics. 2017-12-7

[2]
Dual radiolabeling as a technique to track nanocarriers: the case of gold nanoparticles.

Molecules. 2015-7-16

[3]
Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines.

Drug Deliv Transl Res. 2014-6

[4]
A case-study investigating the physicochemical characteristics that dictate the function of a liposomal adjuvant.

Hum Vaccin Immunother. 2013-4-12

本文引用的文献

[1]
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response.

J Control Release. 2010-4-8

[2]
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.

J Control Release. 2009-10-26

[3]
[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.

Nucl Med Biol. 2009-7

[4]
Adjuvant properties of a simplified C32 monomycolyl glycerol analogue.

Bioorg Med Chem Lett. 2009-4-1

[5]
Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres.

J Drug Target. 2008-8

[6]
PLGA microspheres for the delivery of a novel subunit TB vaccine.

J Drug Target. 2008-5

[7]
Environmental scanning electron microscopy offers real-time morphological analysis of liposomes and niosomes.

J Liposome Res. 2007

[8]
Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.

J Control Release. 2007-5-14

[9]
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice.

J Pharm Pharmacol. 2006-6

[10]
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Biochim Biophys Acta. 2005-12-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索